Adecatumumab (Anti-EpCAM / TROP1 / CD326)

Adecatumumab (Anti-EpCAM / TROP1 / CD326) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2512
Sku # A2512-1mg*25
Pricing 1mg*25, $2970.00
Feedback